Date(s) - 06/17/2019 - 06/21/2019
Crowne Plaza Brussels - Le Palace
NAMSA invites you to meet with our team of regulatory experts at the upcoming MedTech Summit in Brussels, Belgium on 17-21 June. This event will focus on regulatory expectations that follow the EU’s Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) implementation, as well as regulatory and clinical strategies, post-market surveillance and vigilance, emerging market requirements and more.
NAMSA Education Session
18 June 2019 | 15:55–16:25 CEST
Post-Market Clinical Follow Up: What do we need to do and how can we do it?
Presented by Deborah Klestadt; Clinical Study Manager, NAMSA
This session will highlight and discuss:
- The new requirements for PMCF
- Clarification of devices that require PMCF
- Enabling internal systems to provide clinical data visibility
- Utilizing surveys, customer feedback and field change orders to successfully implement PMCF
NAMSA’s medical device development experts will be available throughout the conference for complimentary consultations. We welcome the opportunity to discuss the most efficient and cost-effective pathways to market based on your unique product development requirements. We’ll also walk you through our latest success story, which discusses the significant milestones that NAMSA achieved in partnership with Dental manufacturer, Solvay Dental 360, including information on how the organization saved $7.5M and 12 months in 510(k) development costs.
Please contact us at email@example.com to schedule your consultation time! We look forward to meeting you.